Publications

Found 3 results
Filters: Author is G.N. Zhang  [Clear All Filters]
2016
W. Dong, Zhang, G. N., Gao, S. H., Dong, W., Zhang, G. N., Gao, S. H., Dong, W., Zhang, G. N., and Gao, S. H., Preliminary in vitro analysis of mechanism of cardiac microvascular endothelial barrier function, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS We thank all coauthors for their contribution to this study. REFERENCES Barabutis N, Dimitropoulou C, Birmpas C, Joshi A, et al (2015). p53 protects against LPS-induced lung endothelial barrier dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 308: L776-L787. http://dx.doi.org/10.1152/ajplung.00334.2014 Cao J, Tsenovoy PL, Thompson EA, Falck JR, et al (2015). Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway. Prostaglandins Other Lipid Mediat. 116-117: 76-86. http://dx.doi.org/10.1016/j.prostaglandins.2015.01.002 Conrad KP, Davison JM, et al (2014). The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am. J. Physiol. Renal Physiol. 306: F1121-F1135. http://dx.doi.org/10.1152/ajprenal.00042.2014 Coppiello G, Collantes M, Sirerol-Piquer MS, Vandenwijngaert S, et al (2015). Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake. Circulation 131: 815-826. http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013721 Dixon DL, Mayne GC, Griggs KM, De Pasquale CG, et al (2013). Chronic elevation of pulmonary microvascular pressure in chronic heart failure reduces bi-directional pulmonary fluid flux. Eur. J. Heart Fail. 15: 368-375. http://dx.doi.org/10.1093/eurjhf/hfs201 Dull RO, Cluff M, Kingston J, Hill D, et al (2012). Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L816-L828. http://dx.doi.org/10.1152/ajplung.00080.2011 Hirase T, Node K, et al (2012). Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 302: H499-H505. http://dx.doi.org/10.1152/ajpheart.00325.2011 Horckmans M, Esfahani H, Beauloye C, Clouet S, et al (2015). Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation. J. Immunol. 194: 1874-1881. http://dx.doi.org/10.4049/jimmunol.1401364 Jacob M, Saller T, Chappell D, Rehm M, et al (2013). Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res. Cardiol. 108: 347. http://dx.doi.org/10.1007/s00395-013-0347-z Joshi MS, Williams D, Horlock D, Samarasinghe T, et al (2015). Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol. Diab. Vasc. Dis. Res. 12: 208-216. http://dx.doi.org/10.1177/1479164114565629 Lu Z, Li Y, Jin J, Zhang X, et al (2015). GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS. Atherosclerosis 240: 163-173. http://dx.doi.org/10.1016/j.atherosclerosis.2015.03.013 Masterson C, Jerkic M, Curley GF, Laffey JG, et al (2015). Mesenchymal stromal cell therapies: potential and pitfalls for ARDS. Minerva Anestesiol. 81: 179-194. Moreira RS, Irigoyen M, Sanches TR, Volpini RA, et al (2014). Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307: R514-R524. http://dx.doi.org/10.1152/ajpregu.00445.2013 Murray JF, et al (2011). Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung Dis. 15: 155-160, i. Noyes AM, Dua K, Devadoss R, Chhabra L, et al (2014). Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J. Diabetes 5: 868-876. http://dx.doi.org/10.4239/wjd.v5.i6.868 Ocak G, Drechsler C, Vossen CY, Vos HL, et al (2014). Single nucleotide variants in the protein C pathway and mortality in dialysis patients. PLoS One 9: e97251. http://dx.doi.org/10.1371/journal.pone.0097251 Rusu MC, Poalelungi CV, Vrapciu AD, Nicolescu MI, et al (2015). Endocardial tip cells in the human embryo - facts and hypotheses. PLoS One 10: e0115853. http://dx.doi.org/10.1371/journal.pone.0115853 Saavedra JM, et al (2012). Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin. Sci. 123: 567-590. http://dx.doi.org/10.1042/CS20120078 Saeed M, Hetts SW, Jablonowski R, Wilson MW, et al (2014). Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J. Cardiol. 6: 1192-1208. http://dx.doi.org/10.4330/wjc.v6.i11.1192 Willer EA, Malli R, Bondarenko AI, Zahler S, et al (2012). The vascular barrier-protecting hawthorn extract WS® 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathway. J. Mol. Cell. Cardiol. 53: 567-577. http://dx.doi.org/10.1016/j.yjmcc.2012.07.002 Xie F, Feng L, Cai W, Qiu Y, et al (2015). Vaccarin promotes endothelial cell proliferation in association with neovascularization in vitro and in vivo. Mol. Med. Rep. 12: 1131-1136.
W. Dong, Zhang, G. N., Gao, S. H., Dong, W., Zhang, G. N., Gao, S. H., Dong, W., Zhang, G. N., and Gao, S. H., Preliminary in vitro analysis of mechanism of cardiac microvascular endothelial barrier function, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS We thank all coauthors for their contribution to this study. REFERENCES Barabutis N, Dimitropoulou C, Birmpas C, Joshi A, et al (2015). p53 protects against LPS-induced lung endothelial barrier dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 308: L776-L787. http://dx.doi.org/10.1152/ajplung.00334.2014 Cao J, Tsenovoy PL, Thompson EA, Falck JR, et al (2015). Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway. Prostaglandins Other Lipid Mediat. 116-117: 76-86. http://dx.doi.org/10.1016/j.prostaglandins.2015.01.002 Conrad KP, Davison JM, et al (2014). The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am. J. Physiol. Renal Physiol. 306: F1121-F1135. http://dx.doi.org/10.1152/ajprenal.00042.2014 Coppiello G, Collantes M, Sirerol-Piquer MS, Vandenwijngaert S, et al (2015). Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake. Circulation 131: 815-826. http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013721 Dixon DL, Mayne GC, Griggs KM, De Pasquale CG, et al (2013). Chronic elevation of pulmonary microvascular pressure in chronic heart failure reduces bi-directional pulmonary fluid flux. Eur. J. Heart Fail. 15: 368-375. http://dx.doi.org/10.1093/eurjhf/hfs201 Dull RO, Cluff M, Kingston J, Hill D, et al (2012). Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L816-L828. http://dx.doi.org/10.1152/ajplung.00080.2011 Hirase T, Node K, et al (2012). Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 302: H499-H505. http://dx.doi.org/10.1152/ajpheart.00325.2011 Horckmans M, Esfahani H, Beauloye C, Clouet S, et al (2015). Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation. J. Immunol. 194: 1874-1881. http://dx.doi.org/10.4049/jimmunol.1401364 Jacob M, Saller T, Chappell D, Rehm M, et al (2013). Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res. Cardiol. 108: 347. http://dx.doi.org/10.1007/s00395-013-0347-z Joshi MS, Williams D, Horlock D, Samarasinghe T, et al (2015). Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol. Diab. Vasc. Dis. Res. 12: 208-216. http://dx.doi.org/10.1177/1479164114565629 Lu Z, Li Y, Jin J, Zhang X, et al (2015). GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS. Atherosclerosis 240: 163-173. http://dx.doi.org/10.1016/j.atherosclerosis.2015.03.013 Masterson C, Jerkic M, Curley GF, Laffey JG, et al (2015). Mesenchymal stromal cell therapies: potential and pitfalls for ARDS. Minerva Anestesiol. 81: 179-194. Moreira RS, Irigoyen M, Sanches TR, Volpini RA, et al (2014). Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307: R514-R524. http://dx.doi.org/10.1152/ajpregu.00445.2013 Murray JF, et al (2011). Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung Dis. 15: 155-160, i. Noyes AM, Dua K, Devadoss R, Chhabra L, et al (2014). Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J. Diabetes 5: 868-876. http://dx.doi.org/10.4239/wjd.v5.i6.868 Ocak G, Drechsler C, Vossen CY, Vos HL, et al (2014). Single nucleotide variants in the protein C pathway and mortality in dialysis patients. PLoS One 9: e97251. http://dx.doi.org/10.1371/journal.pone.0097251 Rusu MC, Poalelungi CV, Vrapciu AD, Nicolescu MI, et al (2015). Endocardial tip cells in the human embryo - facts and hypotheses. PLoS One 10: e0115853. http://dx.doi.org/10.1371/journal.pone.0115853 Saavedra JM, et al (2012). Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin. Sci. 123: 567-590. http://dx.doi.org/10.1042/CS20120078 Saeed M, Hetts SW, Jablonowski R, Wilson MW, et al (2014). Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J. Cardiol. 6: 1192-1208. http://dx.doi.org/10.4330/wjc.v6.i11.1192 Willer EA, Malli R, Bondarenko AI, Zahler S, et al (2012). The vascular barrier-protecting hawthorn extract WS® 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathway. J. Mol. Cell. Cardiol. 53: 567-577. http://dx.doi.org/10.1016/j.yjmcc.2012.07.002 Xie F, Feng L, Cai W, Qiu Y, et al (2015). Vaccarin promotes endothelial cell proliferation in association with neovascularization in vitro and in vivo. Mol. Med. Rep. 12: 1131-1136.
W. Dong, Zhang, G. N., Gao, S. H., Dong, W., Zhang, G. N., Gao, S. H., Dong, W., Zhang, G. N., and Gao, S. H., Preliminary in vitro analysis of mechanism of cardiac microvascular endothelial barrier function, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS We thank all coauthors for their contribution to this study. REFERENCES Barabutis N, Dimitropoulou C, Birmpas C, Joshi A, et al (2015). p53 protects against LPS-induced lung endothelial barrier dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 308: L776-L787. http://dx.doi.org/10.1152/ajplung.00334.2014 Cao J, Tsenovoy PL, Thompson EA, Falck JR, et al (2015). Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway. Prostaglandins Other Lipid Mediat. 116-117: 76-86. http://dx.doi.org/10.1016/j.prostaglandins.2015.01.002 Conrad KP, Davison JM, et al (2014). The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am. J. Physiol. Renal Physiol. 306: F1121-F1135. http://dx.doi.org/10.1152/ajprenal.00042.2014 Coppiello G, Collantes M, Sirerol-Piquer MS, Vandenwijngaert S, et al (2015). Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake. Circulation 131: 815-826. http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013721 Dixon DL, Mayne GC, Griggs KM, De Pasquale CG, et al (2013). Chronic elevation of pulmonary microvascular pressure in chronic heart failure reduces bi-directional pulmonary fluid flux. Eur. J. Heart Fail. 15: 368-375. http://dx.doi.org/10.1093/eurjhf/hfs201 Dull RO, Cluff M, Kingston J, Hill D, et al (2012). Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L816-L828. http://dx.doi.org/10.1152/ajplung.00080.2011 Hirase T, Node K, et al (2012). Endothelial dysfunction as a cellular mechanism for vascular failure. Am. J. Physiol. Heart Circ. Physiol. 302: H499-H505. http://dx.doi.org/10.1152/ajpheart.00325.2011 Horckmans M, Esfahani H, Beauloye C, Clouet S, et al (2015). Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation. J. Immunol. 194: 1874-1881. http://dx.doi.org/10.4049/jimmunol.1401364 Jacob M, Saller T, Chappell D, Rehm M, et al (2013). Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res. Cardiol. 108: 347. http://dx.doi.org/10.1007/s00395-013-0347-z Joshi MS, Williams D, Horlock D, Samarasinghe T, et al (2015). Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol. Diab. Vasc. Dis. Res. 12: 208-216. http://dx.doi.org/10.1177/1479164114565629 Lu Z, Li Y, Jin J, Zhang X, et al (2015). GPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS. Atherosclerosis 240: 163-173. http://dx.doi.org/10.1016/j.atherosclerosis.2015.03.013 Masterson C, Jerkic M, Curley GF, Laffey JG, et al (2015). Mesenchymal stromal cell therapies: potential and pitfalls for ARDS. Minerva Anestesiol. 81: 179-194. Moreira RS, Irigoyen M, Sanches TR, Volpini RA, et al (2014). Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307: R514-R524. http://dx.doi.org/10.1152/ajpregu.00445.2013 Murray JF, et al (2011). Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung Dis. 15: 155-160, i. Noyes AM, Dua K, Devadoss R, Chhabra L, et al (2014). Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J. Diabetes 5: 868-876. http://dx.doi.org/10.4239/wjd.v5.i6.868 Ocak G, Drechsler C, Vossen CY, Vos HL, et al (2014). Single nucleotide variants in the protein C pathway and mortality in dialysis patients. PLoS One 9: e97251. http://dx.doi.org/10.1371/journal.pone.0097251 Rusu MC, Poalelungi CV, Vrapciu AD, Nicolescu MI, et al (2015). Endocardial tip cells in the human embryo - facts and hypotheses. PLoS One 10: e0115853. http://dx.doi.org/10.1371/journal.pone.0115853 Saavedra JM, et al (2012). Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin. Sci. 123: 567-590. http://dx.doi.org/10.1042/CS20120078 Saeed M, Hetts SW, Jablonowski R, Wilson MW, et al (2014). Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J. Cardiol. 6: 1192-1208. http://dx.doi.org/10.4330/wjc.v6.i11.1192 Willer EA, Malli R, Bondarenko AI, Zahler S, et al (2012). The vascular barrier-protecting hawthorn extract WS® 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathway. J. Mol. Cell. Cardiol. 53: 567-577. http://dx.doi.org/10.1016/j.yjmcc.2012.07.002 Xie F, Feng L, Cai W, Qiu Y, et al (2015). Vaccarin promotes endothelial cell proliferation in association with neovascularization in vitro and in vivo. Mol. Med. Rep. 12: 1131-1136.